Renal Function-Based Contrast Dosing to Define Safe Limits of Radiographic Contrast Media in Patients Undergoing Percutaneous Coronary Interventions

作者: Hitinder S Gurm , Simon R Dixon , Dean E Smith , David Share , Thomas LaLonde

DOI: 10.1016/J.JACC.2011.05.023

关键词:

摘要: Objectives The aim of this study was to evaluate the association between calculated creatinine clearance (CCC)-based contrast dose and renal complications in patients undergoing percutaneous coronary interventions (PCI). Background Excess volumes media are associated with cardiac procedures. Because excreted by kidney, we hypothesized that a estimation on basis CCC would provide simple strategy define safe media. Methods We assessed CCC-based risk contrast-induced nephropathy (CIN) need for in-hospital dialysis 58,957 PCI enrolled BMC2 (Blue Cross Blue Shield Michigan Cardiovascular Consortium) registry from 2007 2008. Patients receiving at time procedure were excluded. Results CIN requiring (NRD) directly increasing volume adjusted function. NRD approached significance when ratio dose/CCC exceeded 2 (adjusted odds [OR] CIN: 1.16, 95% confidence interval [CI]: 0.98 1.37, OR NRD: 1.72, CI: 0.9 3.27) dramatically elevated exceeding 3 1.46, 1.27 1.66, 1.89, 1.21 2.94). Conclusions Our supports minimizing dysfunction. A estimated function planned restricted less than thrice preferably twice might be valuable reducing NRD.

参考文章(29)
Warren K. Laskey, Charles Jenkins, Faith Selzer, Oscar C. Marroquin, Robert L. Wilensky, Ruchira Glaser, Howard A. Cohen, David R. Holmes, Volume-to-creatinine clearance ratio : A pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention Journal of the American College of Cardiology. ,vol. 50, pp. 584- 590 ,(2007) , 10.1016/J.JACC.2007.03.058
Hitinder S Gurm, Dean E Smith, J Stewart Collins, David Share, Arthur Riba, Andrew J Carter, Thomas LaLonde, Eva Kline-Rogers, Michael O’Donnell, Hameem Changezi, Marcel Zughaib, Robert Safian, Mauro Moscucci, Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2), The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention: insights from a large regional registry of contemporary percutaneous coronary intervention. Journal of the American College of Cardiology. ,vol. 51, pp. 529- 535 ,(2008) , 10.1016/J.JACC.2007.09.053
Michael Reed, Pascal Meier, Umesh U. Tamhane, Kathy B. Welch, Mauro Moscucci, Hitinder S. Gurm, The Relative Renal Safety of Iodixanol Compared With Low-Osmolar Contrast Media JACC: Cardiovascular Interventions. ,vol. 2, pp. 645- 654 ,(2009) , 10.1016/J.JCIN.2009.05.002
Donald W. Cockcroft, Henry Gault, Prediction of Creatinine Clearance from Serum Creatinine Nephron. ,vol. 16, pp. 31- 41 ,(1976) , 10.1159/000180580
Ricardo G. Cigarroa, Richard A. Lange, Russel H. Williams, David Hillis, Dosing of contrast material to prevent contrast nephropathy in patients with renal disease The American Journal of Medicine. ,vol. 86, pp. 649- 652 ,(1989) , 10.1016/0002-9343(89)90437-3
Rosario V Freeman, Michael O’Donnell, David Share, William L Meengs, Eva Kline-Rogers, Vivian L Clark, Anthony C DeFranco, Kim A Eagle, John G McGinnity, Kirit Patel, Ann Maxwell-Eward, Diane Bondie, Mauro Moscucci, Blue Cross Blue Shield of Michigan Cardiovascular Consortium, Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. American Journal of Cardiology. ,vol. 90, pp. 1068- 1073 ,(2002) , 10.1016/S0002-9149(02)02771-6
Alain Moise, Bernard Clément, Pierre Ducimetière, Martial G. Bourassa, Comparison of receiver operating curves derived from the same population: a bootstrapping approach Computers and Biomedical Research. ,vol. 18, pp. 125- 131 ,(1985) , 10.1016/0010-4809(85)90039-4
Brahmajee K. Nallamothu, Kaveh G. Shojania, Sanjay Saint, Timothy P. Hofer, H. David Humes, Mauro Moscucci, Eric R. Bates, Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. The American Journal of Medicine. ,vol. 117, pp. 938- 947 ,(2004) , 10.1016/J.AMJMED.2004.06.046
Aine M. Kelly, Ben Dwamena, Paul Cronin, Steven J. Bernstein, Ruth C. Carlos, Meta-analysis: Effectiveness of Drugs for Preventing Contrast-Induced Nephropathy Annals of Internal Medicine. ,vol. 148, pp. 284- 294 ,(2008) , 10.7326/0003-4819-148-4-200802190-00007
Joel K. Kahn, Barry D. Rutherford, David R. McConahay, Warren L. Johnson, Lee V. Giorgi, Thomas M. Shimshak, Geoffrey O. Hartzler, High-dose contrast agent administration during complex coronary angioplasty American Heart Journal. ,vol. 120, pp. 533- 536 ,(1990) , 10.1016/0002-8703(90)90006-J